Abstract | BACKGROUND: Our previous study revealed that astragaloside IV (AS-IV) effectively improved gestational diabetes mellitus (GDM) by reducing hepatic gluconeogenesis. Due to the importance of placental oxidative stress, we further explored the protective role of AS-IV on placental oxidative stress in GDM. METHODS: First, non-pregnant mice were orally administrated with AS-IV to evaluate its safety and effect. Then GDM mice were orally administered with AS-IV for 20 days and its effect on the symptoms of GDM, placental oxidative stress, secretions of inflammatory cytokines, as well as toll-like receptor 4 (TLR4)/NF-κB signaling pathway, were evaluated. RESULTS: CONCLUSION: AS-IV effectively protected against GDM by alleviating placental oxidative stress and inflammation, in which TLR4/NF-κB might be involved.
|
Authors | Ling Zhou, Ruixue Zhang, Shuangyan Yang, Yaguang Zhang, Dandan Shi |
Journal | Endocrine connections
(Endocr Connect)
Vol. 9
Issue 9
Pg. 939-945
(Oct 2020)
ISSN: 2049-3614 [Print] England |
PMID | 33006955
(Publication Type: Journal Article)
|